Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. The Company’s multi antigen recognizing (MAR)-T cell technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, which are tumor targets, and kill tumor cells expressing those targets. These T cells are designed to recognize multiple tumor targets to produce broad-spectrum anti-tumor activity. It is developing two product candidates, including an Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601) and an Off-the-Shelf (OTS) product in various indications (MT-401-OTS). It has developed MT-601 to recognize multiple target antigens expressed by the tumor, thereby limiting tumor adaptation by negative antigen selection or downregulation.
Find out what a historical investment in Marker Therapeutics Inc would be worth today using our MRKR stock calculator.
Buying MRKR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Marker Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in MRKR
What is the ticker symbol of Marker Therapeutics Inc?
The ticker symbol for Marker Therapeutics Inc is MRKR.
How much is one share of MRKR?
One share of MRKR is valued at $1.32 as of 20 November 2026.
What is the market capitalisation of Marker Therapeutics Inc MRKR?
As of 20 November 2026 Marker Therapeutics Inc has a market cap of $14.23M.
What is the 52-week high for Marker Therapeutics Inc stock?
The Marker Therapeutics Inc 52-week high stock price is $2.46.
What is the 52-week low for Marker Therapeutics Inc stock?
The Marker Therapeutics Inc 52-week low stock price is $0.81.
Can I buy MRKR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MRKR shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MRKR on Stake
Buy MRKR from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of MRKR from only US$10 with fractional shares